Adherence to Gastro-protection in Non-steroidal Anti-inflammatory Drug (NSAID) Using Patients

Compliance of Gastroprotection Treatment in the Prevention of Gastrointestinal Risk in Non-Steroidal Anti-inflammatory Drug (NSAID) Using Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00699725

Acronym

GADES

Enrollment

2000

Registered

2008-06-18

Start date

2008-05-31

Completion date

2009-01-31

Last updated

2010-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Compliance, Gastroprotector Therapy, Risk Factors

Keywords

Compliance, gastroprotector therapy, NSAID, risk factors

Brief summary

Prospective multicentric study to evaluate the compliance of gastroprotective treatment in NSAID patients at risk of GI complications. Secondary objectives: To identify the factors associated to treatment compliance (both NSAID and PPI), to evaluate the relationship between compliance and NSAID-associated GI events

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Signed informed consent * Patients consulting to the specialized care clinics who have been prescribed NSAID and gastroprotection for at least 15 days following standard clinical practice.

Exclusion criteria

* Any gastroprotective treatment prescribed for other condition than NSAID-related gastrointestinal event prevention

Design outcomes

Primary

Measure	Time frame
Adherence to gastroprotection treatment	End of follow-up (3-5 weeks)

Secondary

Measure	Time frame
Identify factors associated with treatment compliance	End of follow-up
Evaluate the relationship among GI events and treatment compliance	End of follow-up

Countries

Spain

Outcome results